Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 53 results.
User Information
Export Records
  1. 1.   Systemic HIV and SIV latency reversal via non-canonical NF-kappa B signalling in vivo
  2. Nixon, Christopher C; Mavigner, Maud; Sampey, Gavin C; Brooks, Alyssa D; Spagnuolo, Rae Ann; Irlbeck, David M; Mattingly, Cameron; Ho, Phong T; Schoof, Nils; Cammon, Corinne G; Tharp, Greg K; Kanke, Matthew; Wang, Zhang; Cleary, Rachel A; Upadhyay, Amit A; De, Chandrav; Wills, Saintedym R; Falcinelli, Shane D; Galardi, Cristin; Walum, Hasse; Schramm, Nathaniel J; Deutsch, Jennifer; Lifson,Jeffrey; Fennessey,Christine; Keele,Brandon; Jean, Sherrie; Maguire, Sean; Liao, Baolin; Browne, Edward P; Ferris, Robert G; Brehm, Jessica H; Favre, David; Vanderford, Thomas H; Bosinger, Steven E; Jones, Corbin D; Routy, Jean-Pierre; Archin, Nancie M; Margolis, David M; Wahl, Angela; Dunham, Richard M; Silvestri, Guido; Chahroudi, Ann; Garcia, J Victor
  3. Nature. 2020, Jan 22;
  1. 2.   Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controller
  2. Migueles, Stephen A.; Chairez, Cheryl; Lin, Siying; Cavil, Noah; Rosenthal, Danielle M.; Pooran, Milad; Natarajan,Ven; Rupert,Adam; Dewar,Robin; Rehman, Tauseef; Sherman,Brad; Adelsberger,Joe; Leitman, Susan F.; Stroncek, David; Morse, Caryn G.; Connors, Mark; Lane, H. Clifford; Kovacs, Joseph A.
  3. JCI INSIGHT. 2019, SEP 19; 4(18):
  1. 3.   No evidence of ongoing HIV replication or compartmentalization in tissues during combination antiretroviral therapy: Implications for HIV eradication
  2. Bozzi, G; Simonetti, F R; Watters, S A; Anderson, E M; Gouzoulis, M; Kearney,Mary; Rote, P; Lange,Camille; Shao,Wei; Gorelick,Robert; Fullmer,Brandie; Kumar, S; Wank, S; Hewitt, S; Kleiner, D E; Hattori, J; Bale,Michael; Hill,Shawn; Bell,Jennifer; Rehm, C; Grossman,Zehava; Yarchoan, R; Uldrick, T; Maldarelli,Frank
  3. Science advances. 2019, Sep; 5(9): eaav2045.
  1. 4.   Viral, immunologic, and clinical features of primary effusion lymphoma
  2. Lurain, Kathryn; Polizzotto, Mark N.; Aleman, Karen; Bhutani, Manisha; Wyvill, Kathleen M.; Goncalves, Priscila H.; Ramaswami, Ramya; Marshall,Vickie; Miley,Wendell; Steinberg, Seth M.; Little, Richard F.; Wilson, Wyndham; Filie, Armando C.; Pittaluga, Stefania; Jaffe, Elaine S.; Whitby,Denise; Yarchoan, Robert; Uldrick, Thomas S.
  3. Blood. 2019, Apr 18; 133(16): 1753-1761.
  1. 5.   Disruption of latent HIV in vivo during the clearance of actinic keratosis by ingenol mebutate
  2. Jiang, Guochun; Maverakis, Emanual; Cheng, Michelle Y.; Elsheikh, Maher M.; Deleage,Claire; Mendez-Lagares, Gema; Shimoda, Michiko; Yukl, Steven A.; Hartigan-O'Connor, Dennis J.; Thompson, George R.; Estes,Jake; Wong, Joseph K.; Dandekar, Satya
  3. JCI insight. 2019, Apr 4; 4(7): pii: 126027.
  1. 6.   No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1-Infected Patients Receiving Antiretroviral Therapy
  2. Gandhi, R. T.; Coombs, R. W.; Chan, E. S.; Bosch, R. J.; Zheng, L.; Margolis, D. M.; Read, S.; Kallungal, B.; Chang, M.; Goecker, E. A.; Wiegand, A.; Kearney, M.; Jacobson, J. M.; D'Aquila, R.; Lederman, M. M.; Mellors, J. W.; Eron, J. J.; AIDS Clinical Trials Group (ACTG) A5244 Team
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2012, Mar; 59(3): 229-235.
  1. 7.   Prevalence of Etravirine-Associated Mutations in Clinical Samples With Genotypic Resistance to Nevirapine and Efavirenz in Brazilian Clinics
  2. Martins, A. N.; Arruda, M. B.; Aleixo, A. W.; Pires, A. F.; Greco, D. B.; Brindeiro, R. D.; Tanuri, A.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2011, Aug; 57: S193-S196.
  1. 8.   Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines
  2. Gil, C.; Climent, N.; Garcia, F.; Hurtado, C.; Nieto-Marquez, S.; Leon, A.; Garcia, M. T.; Rovira, C.; Miralles, L.; Dalmau, J.; Pumarola, T.; Almela, M.; Martinez-Picado, J.; Lifson, J. D.; Zamora, L.; Miro, J. M.; Brander, C.; Clotet, B.; Gallart, T.; Gatell, J. M.
  3. Vaccine. 2011, Aug; 29(34): 5711-5724.
  1. 9.   Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes
  2. Srinivasula, S.; Lempicki, R. A.; Adelsberger, J. W.; Huang, C. Y.; Roark, J.; Lee, P. I.; Rupert, A.; Stevens, R.; Sereti, I.; Lane, H. C.; Di Mascio, M.; Kovacs, J. A.
  3. Blood. 2011, Jul; 118(2): 262-270.
  1. 10.   Association of Host Genetic Risk Factors With the Course of Cytomegalovirus Retinitis in Patients Infected With Human Immunodeficiency Virus
  2. Sezgin, E.; van Natta, M. L.; Ahuja, A.; Lyon, A.; Srivastava, S.; Troyer, J. L.; O'Brien, S. J.; Jabs, D. A.; Studies Ocular Complications, A.
  3. American Journal of Ophthalmology. 2011, Jun; 151(6): 999-1006.
  1. 11.   Mechanisms of HIV-1 drug resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
  2. Nikolenko, G. N.; Kotelkin, A. T.; Oreshkova, S. F.; Ilyichev, A. A.
  3. Molecular Biology. 2011, Feb; 45(1): 93-109.
  1. 12.   Genetic Diversity of Simian Immunodeficiency Virus Encoding HIV-1 Reverse Transcriptase Persists in Macaques despite Antiretroviral Therapy
  2. Kearney, M.; Spindler, J.; Shao, W.; Maldarelli, F.; Palmer, S.; Hu, S. L.; Lifson, J. D.; KewalRamani, V. N.; Mellors, J. W.; Coffin, J. M.; Ambrose, Z.
  3. Journal of Virology. 2011, Jan; 85(2): 1067-1076.
  1. 13.   Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy
  2. McKinnon, J. E.; Delgado, R.; Pulido, F.; Shao, W.; Arribas, J. R.; Mellors, J. W.
  3. Antiviral Therapy. 2011 16(5): 725-732.
  1. 14.   Recognition and Management of Significant Drug Interactions in HIV Patients: Challenges in Using Available Data to Guide Therapy
  2. Pau, A. K.; Boyd, S. D.
  3. Clinical Pharmacology & Therapeutics. 2010, Nov; 88(5): 712-719.
  1. 15.   Evidence of dysregulation of dendritic cells in primary HIV infection
  2. Sabado, R. L.; O'Brien, M.; Subedi, A.; Qin, L.; Hu, N.; Taylor, E.; Dibben, O.; Stacey, A.; Fellay, J.; Shianna, K. V.; Siegal, F.; Shodell, M.; Shah, K.; Larsson, M.; Lifson, J.; Nadas, A.; Marmor, M.; Hutt, R.; Margolis, D.; Garmon, D.; Markowitz, M.; Valentine, F.; Borrow, P.; Bhardwaj, N.
  3. Blood. 2010, Nov; 116(19): 3839-3852.
  1. 16.   Mechanisms underlying gamma delta T-cell subset perturbations in SIV-infected Asian rhesus macaques
  2. Harris, L. D.; Klatt, N. R.; Vinton, C.; Briant, J. A.; Tabb, B.; Ladell, K.; Lifson, J.; Estes, J. D.; Price, D. A.; Hirsch, V. M.; Brenchley, J. M.
  3. Blood. 2010, Nov; 116(20): 4148-4157.
  1. 17.   The Effect of Leflunomide on Cycling and Activation of T-Cells in HIV-1-Infected Participants
  2. Read, S. W.; DeGrezia, M.; Ciccone, E. J.; DerSimonian, R.; Higgins, J.; Adelsberger, J. W.; Starling, J. M.; Rehm, C.; Sereti, I.
  3. Plos One. 2010, Aug; 5(8): 7.
  1. 18.   MYH9 Genetic Variants Associated With Glomerular Disease: What Is the Role for Genetic Testing?
  2. Kopp, J. B.; Winkler, C. A.; Nelson, G. W.
  3. Seminars in Nephrology. 2010, Jul; 30(4): 409-417.
  1. 19.   D-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS
  2. Porter, B. O.; Ouedraogo, G. L.; Hodge, J. N.; Smith, M. A.; Pau, A.; Roby, G.; Kwan, R.; Bishop, R. J.; Rehm, C.; Mican, J.; Sereti, I.
  3. Clinical Immunology. 2010, Jul; 136(1): 42-50.
  1. 20.   Interleukin-27, an Anti-HIV-1 Cytokine, Inhibits Replication of Hepatitis C Virus
  2. Frank, A. C.; Zhang, X. Z.; Katsounas, A.; Bharucha, J. P.; Kottilil, S.; Imamichi, T.
  3. Journal of Interferon and Cytokine Research. 2010, Jun; 30(6): 427-431.
  1. 21.   Specific Human Leukocyte Antigen Class I and II Alleles Associated with Hepatitis C Virus Viremia
  2. Kuniholm, M. H.; Kovacs, A.; Gao, X. J.; Xue, X. N.; Marti, D.; Thio, C. L.; Peters, M. G.; Terrault, N. A.; Greenblatt, R. M.; Goedert, J. J.; Cohen, M. H.; Minkoff, H.; Gange, S. J.; Anastos, K.; Fazzari, M.; Harris, T. G.; Young, M. A.; Strickler, H. D.; Carrington, M.
  3. Hepatology. 2010, May; 51(5): 1514-1522.
  1. 22.   Alterations in Natural Killer Cell Receptor Profiles During HIV Type 1 Disease Progression Among Chronically Infected South African Adults
  2. Wong, A. H. W.; Williams, K.; Reddy, S.; Wilson, D.; Giddy, J.; Alter, G.; Ghebremichael, M.; Carrington, M. N.; Ndung'u, T.; Walker, B. D.; Altfeld, M.; Carr, W. H.
  3. Aids Research and Human Retroviruses. 2010, Apr; 26(4): 459-469.
  1. 23.   Cycling of gut mucosal CD4+T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels
  2. Ciccone, E. J.; Read, S. W.; Mannon, P. J.; Yao, M. D.; Hodge, J. N.; Dewar, R.; Chairez, C. L.; Proschan, M. A.; Kovacs, J. A.; Sereti, I.
  3. Mucosal Immunology. 2010, Mar; 3(2): 172-181.
  1. 24.   Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit
  2. Valentin, A.; von Gegerfelt, A.; Rosati, M.; Miteloudis, G.; Alicea, C.; Bergamaschi, C.; Jalah, R.; Patel, V.; Khan, A. S.; Draghia-Akli, R.; Pavlakis, G. N.; Felber, B. K.
  3. Vaccine. 2010, Feb; 28(8): 1962-1974.
  1. 25.   Immunologic and Virologic Events in Early HIV Infection Predict Subsequent Rate of Progression
  2. Ganesan, A.; Chattopadhyay, P. K.; Brodie, T. M.; Qin, J.; Gu, W. J.; Mascola, J. R.; Michael, N. L.; Follmann, D. A.; Roederer, M.; Infect Dis Clinical Res Program, H. I.
  3. Journal of Infectious Diseases. 2010, Jan; 201(2): 272-284.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel